Raw Materials in Focus: Enabling Platform-Based Development in Advanced Therapies

Thank you - Your Download is Available Below

Raw Materials in Focus: Enabling Platform-Based Development in Advanced Therapies

PDF | 1.9 MB

Raw Materials in Focus: Enabling Platform-Based Development in Advanced Therapies

Abstract:

Advanced Therapy Medicinal Products (ATMPs) are known to address unmet medical needs and challenge the convention of “one drug, one disease” model. Lately, there has been a shift towards a platform-based approach to address the pathological mechanisms to treat diseases.

Learn more in this article, including:

How a platform-based approach to ATMP development can accelerate clinical development while reducing costs
What are the regulatory advantages of this approach compared to the traditional disease targeting approach
Why raw material quality is important to mitigate risk and maintain product integrity

Clear form data

Please Complete the Form

First Name *

Last Name *

E-Mail *

Phone Number *

Company *

Job Title *

Address *

Country *

Postal Code *

I would like to sign up for newsletters from Sartorius (Sartorius AG and its affiliated companies) based of my personal interests.
I can revoke my consent at any time with effect for the future by sending an e-mail to unsubscribe@sartorius.com or by clicking on the "unsubscribe" link in e-mails I have received.

* These fields are required Information on the use of your data can be found in our privacy policy

Thank you - Your Download is Available Below

Raw Materials in Focus: Enabling Platform-Based Development in Advanced Therapies

Raw Materials in Focus: Enabling Platform-Based Development in Advanced Therapies

Please Complete the Form

Complete Form to Access the File